Literature DB >> 24660722

ABLATE: a renal ablation planning algorithm.

Grant D Schmit1, A Nicholas Kurup, Adam J Weisbrod, R Houston Thompson, Stephen A Boorjian, C Thomas Wass, Matthew R Callstrom, Thomas D Atwell.   

Abstract

OBJECTIVE: The purpose of this article is to present the ABLATE renal ablation planning algorithm (Table 1), which is based on anatomic renal tumor characteristics critical to ablation. [Table: see text].
CONCLUSION: ABLATE provides a systematic method for reviewing cross-sectional imaging of renal masses for ablation planning purposes. The goal of this system is to help proceduralists anticipate and manage potential technical challenges of renal ablations to maximize oncologic outcomes and minimize complications.

Entities:  

Mesh:

Year:  2014        PMID: 24660722     DOI: 10.2214/AJR.13.11110

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

Review 1.  Contemporary Status of Percutaneous Ablation for the Small Renal Mass.

Authors:  Benjamin J Shin; Jeffrey Forris Beecham Chick; S William Stavropoulos
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

2.  [Small renal cell carcinoma-active surveillance and ablation].

Authors:  J J Wendler; R Damm; U-B Liehr; T Brunner; M Pech; M Schostak
Journal:  Urologe A       Date:  2018-06       Impact factor: 0.639

Review 3.  Ablative Therapies for the Treatment of Small Renal Masses: a Review of Different Modalities and Outcomes.

Authors:  Nicholas Kavoussi; Noah Canvasser; Jeffrey Caddedu
Journal:  Curr Urol Rep       Date:  2016-08       Impact factor: 3.092

Review 4.  Pneumodissection during Percutaneous Renal Ablation Resulting in Air Embolism: Percutaneous Management and a Review of the Literature.

Authors:  Kamil Arif; Andrew J Gunn
Journal:  Semin Intervent Radiol       Date:  2019-05-22       Impact factor: 1.513

Review 5.  Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy.

Authors:  Serge Ginzburg; Jeffrey J Tomaszewski; Alexander Kutikov
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

6.  Skin-to-tumor Distance Predicts Treatment Failure of T1A Renal Cell Carcinoma Following Percutaneous Cryoablation.

Authors:  Simone L Vernez; Zhamshid Okhunov; Kamaljot Kaler; Ramy F Youssef; Rahul Dutta; Arkadiy Palvanov; Paras Shah; Kathryn Osann; David N Siegel; Igor Lobko; Louis Kavoussi; Ralph V Clayman; Jaime Landman
Journal:  Urology       Date:  2017-06-23       Impact factor: 2.649

Review 7.  Renal Cell Carcinoma Ablation: Preprocedural, Intraprocedural, and Postprocedural Imaging.

Authors:  Winston B Joe; Jessica G Zarzour; Andrew J Gunn
Journal:  Radiol Imaging Cancer       Date:  2019-11-29

Review 8.  [Ablative therapy of small renal masses].

Authors:  M C Kriegmair; N Wagener; S J Diehl; N Rathmann
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

Review 9.  [What can/should be treated in kidney tumors and when].

Authors:  C M Sommer; D F Vollherbst; G M Richter; H U Kauczor; P L Pereira
Journal:  Radiologe       Date:  2017-02       Impact factor: 0.635

Review 10.  Imaging considerations for thermal and radiotherapy ablation of primary and metastatic renal cell carcinoma.

Authors:  Mohammad Haroon; Paul Sathiadoss; Rebecca M Hibbert; Satheesh Krishna Jeyaraj; Christopher Lim; Nicola Schieda
Journal:  Abdom Radiol (NY)       Date:  2021-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.